In:
Cancer, Wiley, Vol. 127, No. 24 ( 2021-12-15), p. 4557-4564
Abstract:
Tumor tissue genomic alterations from primary prostate tumors and metastatic sites show significant heterogeneity, and this suggests possible tumor evolution, natural selection, and/or tumor adaptation. Circulating tumor DNA testing can be a noninvasive, potentially serial assay that may provide a real‐time representation of the evolutionary cancer state throughout therapy.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v127.24
Language:
English
Publisher:
Wiley
Publication Date:
2021
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink